Branding for a new epidemiological study of cancer

Ended Awarded Last action

Contract number
HHSN26100002
Awardee
Awarding agency
Obligated
$69,915

Award facts

Contract value 100% obligated
$69,915.17 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
511199 All Other Publishers
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20910, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 $0
Change Order P00001 $0
Original award $69,915

About this award

The National Cancer Institute issued a delivery order to Palladian Partners, Inc. on February 27, 2018, for branding of a new epidemiological study of cancer, with a ceiling value of $69,915.17.

The order was issued under the NIH Public Information and Communication 2012–2016 indefinite-delivery contract. Place of performance is Silver Spring, MD. The order is firm fixed price with an ultimate completion date of May 31, 2019.

Quick answers

Who was awarded contract HHSN26100002?

HHSN26100002 was awarded to Palladian Partners, Inc. by National Cancer Institute (National Institutes of Health) on February 27, 2018.

How much is contract HHSN26100002 worth?

The government has obligated $69,915 on HHSN26100002.

Is contract HHSN26100002 an order under another contract?

Yes. HHSN26100002 is a delivery order under HHSN263201200060I, an indefinite delivery contract, on NIH Public Information and Communication 2012-2016.

Was contract HHSN26100002 competed?

The extent of competition for HHSN26100002 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award